Europe Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031
The Europe Cellulite Treatment Market would witness market growth of 9.9% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $349.6 Million by 2031. The UK market is exhibiting a CAGR of 8.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 10.7% during (2024 - 2031).
In recent years, skincare products targeting cellulite are also gaining popularity. Some of the ingredients in these products, including caffeine, retinol, and antioxidants, claim to diminish the appearance of cellulite. Caffeine is frequently incorporated into cellulite-targeting skincare products on account of its capacity to reduce fluid retention and enhance circulation, thereby potentially aiding in the reduction of cellulite appearance. Another popular ingredient, retinol, which is a form of vitamin A, is thought to increase skin texture and stimulate collagen production, thereby diminishing the appearance of cellulite. Because they prevent skin damage and enhance general well-being, cellulite-targeting skincare products frequently incorporate antioxidants, including vitamins C and E.
Moreover, the increased prevalence of social media and influencer marketing has contributed to heightened consciousness and endorsement of skincare products that purport to diminish the visual appearance of cellulite. Additionally, the convenience and accessibility of skin care products make them a popular choice for consumers looking to address their cellulite concerns. Skincare products can be easily incorporated into a daily skincare routine and purchased over the counter or online, making them a convenient option for consumers.
The increasing demand for cellulite treatment in Europe can be linked to the high prevalence of overweight adults and physical inactivity in the region. According to Eurostat, the proportion of overweight adults in the EU varied between 37% in Italy and 58% in Croatia for women and between 53% in France and 73% in Croatia for men. Thus, the high prevalence of overweight adults and physical inactivity in Europe suggests a significant potential market for cellulite treatments.
Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Candela Corporation (Syneron Medical)
- Bausch Health Companies, Inc.
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- AbbVie, Inc.
- Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- Hologic, Inc.
- Galderma S.A.
- Zimmer MedizinSysteme GmbH
- Endo International PLC
- Merz Pharma GmbH & Co. KGaA
By Gender
- Female
- Male
- Non-invasive
- Topical
- Minimally Invasive
- Soft Cellulite
- Hard Cellulite
- Edematous
- Clinics & Beauty Centers
- Hospitals
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Cellulite Treatment Market, by Gender
- 1.4.2 Europe Cellulite Treatment Market, by Procedure Type
- 1.4.3 Europe Cellulite Treatment Market, by Cellulite Type
- 1.4.4 Europe Cellulite Treatment Market, by End User
- 1.4.5 Europe Cellulite Treatment Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. Recent Strategies Deployed in Cellulite Treatment Market
- Chapter 5. Europe Cellulite Treatment Market by Gender
- 5.1 Europe Female Market by Country
- 5.2 Europe Male Market by Country
- Chapter 6. Europe Cellulite Treatment Market by Procedure Type
- 6.1 Europe Non-invasive Market by Country
- 6.2 Europe Topical Market by Country
- 6.3 Europe Minimally Invasive Market by Country
- Chapter 7. Europe Cellulite Treatment Market by Cellulite Type
- 7.1 Europe Soft Cellulite Market by Country
- 7.2 Europe Hard Cellulite Market by Country
- 7.3 Europe Edematous Market by Country
- Chapter 8. Europe Cellulite Treatment Market by End User
- 8.1 Europe Clinics & Beauty Centers Market by Country
- 8.2 Europe Hospitals Market by Country
- 8.3 Europe Others Market by Country
- Chapter 9. Europe Cellulite Treatment Market by Country
- 9.1 Germany Cellulite Treatment Market
- 9.1.1 Germany Cellulite Treatment Market by Gender
- 9.1.2 Germany Cellulite Treatment Market by Procedure Type
- 9.1.3 Germany Cellulite Treatment Market by Cellulite Type
- 9.1.4 Germany Cellulite Treatment Market by End User
- 9.2 UK Cellulite Treatment Market
- 9.2.1 UK Cellulite Treatment Market by Gender
- 9.2.2 UK Cellulite Treatment Market by Procedure Type
- 9.2.3 UK Cellulite Treatment Market by Cellulite Type
- 9.2.4 UK Cellulite Treatment Market by End User
- 9.3 France Cellulite Treatment Market
- 9.3.1 France Cellulite Treatment Market by Gender
- 9.3.2 France Cellulite Treatment Market by Procedure Type
- 9.3.3 France Cellulite Treatment Market by Cellulite Type
- 9.3.4 France Cellulite Treatment Market by End User
- 9.4 Russia Cellulite Treatment Market
- 9.4.1 Russia Cellulite Treatment Market by Gender
- 9.4.2 Russia Cellulite Treatment Market by Procedure Type
- 9.4.3 Russia Cellulite Treatment Market by Cellulite Type
- 9.4.4 Russia Cellulite Treatment Market by End User
- 9.5 Spain Cellulite Treatment Market
- 9.5.1 Spain Cellulite Treatment Market by Gender
- 9.5.2 Spain Cellulite Treatment Market by Procedure Type
- 9.5.3 Spain Cellulite Treatment Market by Cellulite Type
- 9.5.4 Spain Cellulite Treatment Market by End User
- 9.6 Italy Cellulite Treatment Market
- 9.6.1 Italy Cellulite Treatment Market by Gender
- 9.6.2 Italy Cellulite Treatment Market by Procedure Type
- 9.6.3 Italy Cellulite Treatment Market by Cellulite Type
- 9.6.4 Italy Cellulite Treatment Market by End User
- 9.7 Rest of Europe Cellulite Treatment Market
- 9.7.1 Rest of Europe Cellulite Treatment Market by Gender
- 9.7.2 Rest of Europe Cellulite Treatment Market by Procedure Type
- 9.7.3 Rest of Europe Cellulite Treatment Market by Cellulite Type
- 9.7.4 Rest of Europe Cellulite Treatment Market by End User
- Chapter 10. Company Profiles
- 10.1 Candela corporation (Syneron Medical)
- 10.1.1 Company Overview
- 10.1.2 Recent strategies and developments:
- 10.1.2.1 Partnerships, Collaborations, and Agreements:
- 10.1.2.2 Product Launches and Product Expansions:
- 10.1.3 SWOT Analysis
- 10.2 Bausch Health Companies, Inc
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Trials and Approvals:
- 10.2.6 SWOT Analysis
- 10.3 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- 10.3.1 Company Overview
- 10.3.2 Recent strategies and developments:
- 10.3.2.1 Partnerships, Collaborations, and Agreements:
- 10.3.2.2 Product Launches and Product Expansions:
- 10.3.3 SWOT Analysis
- 10.4 AbbVie, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Product Launches and Product Expansions:
- 10.4.5.2 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
- 10.5 Hologic, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 SWOT Analysis
- 10.6 Galderma S.A.
- 10.6.1 Company Overview
- 10.6.2 SWOT Analysis
- 10.7 Endo International PLC
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 Recent strategies and developments:
- 10.7.5.1 Trials and Approvals:
- 10.7.5.2 Acquisition and Mergers:
- 10.7.6 SWOT Analysis
- 10.8 Merz Pharma GmbH & Co. KGaA
- 10.8.1 Company Overview
- 10.8.2 SWOT Analysis
- 10.9 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- 10.9.1 Company Overview
- 10.9.2 SWOT Analysis
- 10.10. Zimmer MedizinSysteme GmbH
- 10.10.1 Company Overview
- 10.10.2 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook